Lixoft develops modeling and simulation software for advanced model-based drug development. Lixoft offers powerful and easy solutions for population analysis in pre-clinical and clinical trials, pharmacovigilance and pharmacoepidemiology. Lixoft is driven by two missions:
- allowing the deployment of the most advanced models in pharmacometrics, by combining breakthough statistical methods with unique ease of use;
- advancing translational medicine with communication-enabling tools for a shared ownership all across the drug development continuum.
Lixoft’s technologies are the result of a seven years research program in statistics and modeling, led by Inria on non-linear mixed effect models for advanced population analysis, PK/PD, pre-clinical and clinical trial modeling & simulation.